Leonard S. Schleifer - 19 Nov 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
President & CEO, Director
Signature
/s/**Leonard S. Schleifer
Issuer symbol
REGN
Transactions as of
19 Nov 2021
Net transactions value
-$119,112,839
Form type
4
Filing time
19 Nov 2021, 16:50:44 UTC
Previous filing
20 Aug 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $64,649,807 +239,063 +78% $270.43 543,809 19 Nov 2021 Direct
transaction REGN Common Stock Tax liability $113,109,192 -173,491 -32% $651.96 370,318 19 Nov 2021 Direct
transaction REGN Common Stock Options Exercise $50,380,312 +281,250 +76% $179.13 651,568 19 Nov 2021 Direct
transaction REGN Common Stock Tax liability $121,033,766 -185,646 -28% $651.96 465,922 19 Nov 2021 Direct
holding REGN Common Stock 200,000 19 Nov 2021 2021 GRAT
holding REGN Common Stock 5,874 19 Nov 2021 By 401(k) Plan
holding REGN Common Stock 21,178 19 Nov 2021 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -281,250 -100% $0.000000* 0 19 Nov 2021 Common Stock 281,250 $179.13 Direct F2
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -239,063 -100% $0.000000* 0 19 Nov 2021 Common Stock 239,063 $270.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the reporting person's family members. The reporting person's spouse is a trustee of the trust.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.